Highlights Cue Health Inc.

Equities

HLTH

US2297901009

Real-time Estimate Cboe BZX Other stock markets 14:14:21 2024-05-09 EDT			5-day change	1st Jan Change
0.134 ^USD	+2.29%		-4.14%	-17.42%

04-24	Cue Health Inc. Announces Chief Financial Officer Changes, Effective as of May 13, 2024	CI
04-09	Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request	04-09	CI
North American Morning Briefing : Inflation -2-	03-15	DJ
Earnings Flash (HLTH) CUE HEALTH Posts Q4 Revenue $18.8M, vs. Street Est of $17.7M	03-13	MT
Cue Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-13	CI
Cue Health Inc. Provides Revenue Guidance for the First Quarter of 2024	03-13	CI
Cue Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Earnings Flash (HLTH) CUE HEALTH Reports Q3 Revenue $17.5M, vs. Street Est of $11.2M	11-08	MT
Cue Health Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	11-08	CI
Cue Health Inc. Declares Dividend Distribution	23-09-22	CI
Cue Health Shareholder Tarsadia Seeks Strategic Review, Shareholder Representation on Board	23-09-01	MT
Investor Tarsadia urges Cue Health to review options, add new director	23-08-31	RE
Cue Health Shareholder Tarsadia Seeks Strategic Review, Shareholder Representation on Board	23-08-31	MT
Investor Tarsadia urges Cue Health to review options, add new director	23-08-31	RE
Earnings Flash (HLTH) CUE HEALTH Posts Q2 Revenue $9.9M, vs. Street Est of $8.9M	23-08-09	MT
Cue Health Inc. Provides Revenue Guidance for Third Quarter of 2023	23-08-09	CI
Cue Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Cue Health Gets $28 Million Federal Contract	23-08-04	MT
Cue Health Inc. Announces Award of New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use	23-08-03	CI
Cue Health's COVID-19 Molecular Test Gets US FDA's Marketing Authorization	23-06-06	MT
Cue Health Inc. Receives De Novo Authorization from the U.S. Food and Drug Administration for its Covid-19 Molecular Test	23-06-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cue Health Inc.

Equities

HLTH

US2297901009

Highlights

Filters